TCA Cycle Pathway Metabolic Flux Analysis Service - Creative Proteomics Metabolomics

Q: How does TCA Cycle MFA distinguish oxidative cycling from reductive carboxylation?

By using [U‑ 13 C 5 ]glutamine, oxidative TCA cycling converts α-ketoglutarate (M+5) into M+4 succinate, fumarate, malate, and citrate. In contrast, reverse reductive carboxylation catalyzed by IDH1/2 adds unlabeled CO 2 to [U‑ 13 C 5 ]α-ketoglutarate, generating M+5 isocitrate/citrate and downstream M+3 malate. The ratio of M+5 to M+4 citrate provides an exact metric of the reductive‑to‑oxidative flux fraction.

Q: How do you quantify pyruvate dehydrogenase (PDH) vs. pyruvate carboxylase (PC) entry?

Using [U‑ 13 C 6 ]glucose, PDH decarboxylates pyruvate (M+3) into M+2 acetyl‑CoA, condensing with oxaloacetate to form M+2 citrate. PC carboxylates M+3 pyruvate directly into M+3 oxaloacetate, yielding M+3 malate, aspartate, and M+3/M+5 citrate. Stoichiometric network modeling resolves the relative split ratio between PDH and PC.

Q: Can TCA Cycle MFA quantify anaplerosis from sources other than glutamine?

Yes. By utilizing custom tracers such as [U‑ 13 C 3 ]propionate, [U‑ 13 C 4 ]succinate, or [U‑ 13 C]amino acid mixtures, stoichiometric network modeling quantifies anaplerotic influx through succinyl‑CoA, fumarate, and oxaloacetate.

Q: What statistical metrics validate the calculated TCA cycle fluxes?

Calculated fluxes are validated using global Chi‑square goodness‑of‑fit testing against measurement variance. Furthermore, parameter sensitivity analysis and confidence intervals are computed for reactions to verify that reported flux parameters are mathematically supported by the experimental dataset.

TCA Cycle & Krebs Cycle Metabolic Flux Analysis — Resolving Mitochondrial Velocities

The tricarboxylic acid (TCA) cycle is the central hub of mitochondrial aerobic respiration, generating reducing equivalents (NADH, FADH₂) and supplying biosynthetic carbon skeletons. However, measuring static concentrations of citrate, succinate, or malate cannot reveal whether intermediate accumulation is driven by accelerated anaplerotic influx or downstream enzymatic bottlenecks (e.g. SDH or FH loss of function).

As an essential pathway Spoke within our central carbon metabolic flux analysis and broader metabolic flux analysis service, TCA Cycle MFA tracks ¹³C isotopes through mitochondrial and cytosolic compartments to resolve key metabolic decision nodes:

(i) Pyruvate Entry Routing: The stoichiometric split between oxidative decarboxylation via pyruvate dehydrogenase (PDH, yielding M+2 acetyl-CoA) and carboxylation via pyruvate carboxylase (PC, generating M+3 oxaloacetate), linked to our glycolytic pathway metabolic flux analysis.

(ii) Oxidative vs. Reductive IDH Flux: Forward oxidative TCA cycling (M+4 intermediates from [U-¹³C₅]glutamine) versus reverse reductive carboxylation (IDH1/2 reduction of α-KG to M+5 citrate) supporting lipogenesis under hypoxia or mitochondrial stress.

(iii) Anaplerotic Capacity & Substrate Choice: Fractional contributions of glutaminolysis (GLS/GDH), branched-chain amino acid catabolism, and fatty acid oxidation fueling the cycle.

(iv) Cataplerotic Efflux & Shunt Pathways: Mitochondrial citrate export via the citrate carrier (CIC/SLC25A1) for ACLY cleavage, malate-aspartate shuttling, and GABA shunt bypasses.

Looking for metabolite concentration measurements? If your research objective is quantifying absolute or relative pool sizes of citric acid cycle intermediates (μmol/g or ng/mL) without stable isotope tracing, please visit our Citrate Cycle Metabolism Service.

Analytical Considerations in Mitochondrial & TCA Cycle Fluxomics

TCA cycle fluxomics requires high analytical fidelity to baseline-separate isobaric isomers and account for mitochondrial compartmentation:

Baseline Chromatographic Separation of Isomers: Citrate and isocitrate share identical molecular formulas (C₆H₈O₇, m/z 191.0197) and identical mass isotopologue envelopes. Our optimized LC-MS methods achieve baseline chromatographic resolution, preventing spectral overlap.
Quenching Protocols for Labile Keto Acids: Labile α-keto acids (α-ketoglutarate, oxaloacetate, pyruvate) are prone to non-enzymatic degradation. Rapid low-temperature organic solvent quenching arrests enzymatic interconversion.
Dual LC-MS & GC-MS Orthogonal Profiling: Non-derivatized LC-MS profiles intact dicarboxylic and tricarboxylic acids, while GC-MS-based metabolic flux analysis using silylation derivatization supplies fragment-specific carbon constraints (e.g. malate [M-57]⁺ vs. [M-159]⁺).
Multi-Element Background Deconvolution: Algorithmic matrix deconvolution (IsoCor / AccuCor) strips natural ¹³C, ¹⁵N, ¹⁸O, and silicon isotope background across all target fragment envelopes.

13C & 15N Tracer Selection Matrix for TCA Cycle & Anaplerotic Networks

The choice of isotope tracer dictates which mitochondrial branch points and anaplerotic inputs are mathematically identifiable:

Tracer Substrate	Target TCA Cycle Reaction	Diagnostic MID Readout & Value
[U-¹³C₅]Glutamine	Forward Oxidative TCA Cycling vs. Reductive Carboxylation	Deaminates to [U-¹³C₅]α-KG (M+5). Forward oxidative cycling produces M+4 succinate, fumarate, malate, and citrate. Reverse reductive carboxylation produces M+5 isocitrate/citrate and M+3 malate/fumarate/aspartate. The M+5/M+4 citrate ratio directly reflects the reductive-to-oxidative flux fraction.
[U-¹³C₆]Glucose	PDH vs. PC anaplerotic entry & Krebs cycle throughput	Pyruvate (M+3) processed by PDH yields M+2 acetyl-CoA → M+2 citrate, α-KG, and glutamate. Pyruvate processed by PC yields M+3 oxaloacetate → M+3 malate, aspartate, and M+3/M+5 citrate. Quantifies the stoichiometric PDH:PC split ratio.
[1-¹³C]Glutamine	α-Ketoglutarate dehydrogenase (α-KGDH) net flux	Labels the C1 carboxyl position of glutamine. Forward oxidation through α-KGDH releases C1 as ¹³CO₂, leaving succinate and downstream intermediates unlabeled (M+0). Reductive carboxylation retains C1 in [1-¹³C]citrate (M+1).
Parallel [U-¹³C₆]Glc + [U-¹³C₅]Gln	Global mitochondrial carbon economy & substrate fuel choice	Parallel tracer experiments and joint model fitting resolve the relative fractional contributions of glucose vs. glutamine vs. fatty acids into mitochondrial respiration.

Technical Capabilities for High-Resolution TCA Cycle Flux Analysis

Orthogonal Analytical Platforms: Targeted high-resolution LC-MS and GC-MS data acquisition matched to the polarity and fragmentation needs of organic acids and amino acids.
Isotopic Steady-State and Dynamic Options: Supports isotopic steady-state flux mapping as well as rapid time-course dynamic and INST metabolic flux analysis for evaluating acute mitochondrial perturbations or hypoxia transitions.
Statistical Identifiability and Uncertainty Analysis: Fitted fluxes are evaluated with goodness-of-fit testing and confidence interval assessments to verify parameter identifiability.
Complementary Positional Validation: Where stereospecific carbon atom routing requires orthogonal physical verification, studies can incorporate high-field NMR-based metabolic flux analysis.

End-to-End TCA Cycle Pathway MFA Workflow

Mitochondrial Network Formulation & Tracer Planning

We define carbon atom transition matrices encompassing the TCA cycle, PDH/PC entry, reductive IDH, anaplerosis, and shuttle mechanisms tailored to your biological system.

Isotope Tracing & Sample Quenching

Cells or tissues are incubated with validated [U-¹³C₅]glutamine or [U-¹³C₆]glucose tracers and rapidly harvested using pre-evaluated quenching protocols.

High-Resolution LC-MS & GC-MS Profiling

TCA intermediates (citrate, isocitrate, α-KG, succinate, fumarate, malate) and linked amino acids (glutamate, aspartate) are acquired for mass isotopologue distributions (M+0 to M+n); extracellular rates are measured in parallel.

Natural Abundance Matrix Deconvolution

Raw isotopologue profiles are algorithmically stripped of natural isotope background using IsoCor/AccuCor, verified with pooled quality control (QC) standards.

Mathematical Modeling & Uncertainty Review

Stoichiometric and isotopomer balance equations are fitted to experimental data, followed by goodness-of-fit evaluation and parameter confidence interval estimation.

Publication-Ready Flux Maps & Deliverables

Delivery of comprehensive quantitative datasets, model diagnostics, and publication-oriented vector pathway maps supported by our fluxomics data analysis service.

Six-step workflow for TCA cycle pathway metabolic flux analysis

Sample Preparation & Quenching Guidelines for Mitochondrial TCA MFA

Sample amounts and quenching procedures are finalized during feasibility review based on mitochondrial density and matrix type:

Sample Type	Typical Input Guidelines	Harvesting & Quenching Principles	Storage & Transport
Adherent Cultured Cells	Typically 1–5 × 10⁶ cells (60 mm dish), confirmed by pilot assessment	Aspirate tracer medium rapidly, add pre-cooled organic extraction solvent, cell detachment on dry ice/ice. Avoid prolonged washes.	Store at −80 °C; ship on dry ice
Suspension Cultured Cells	Typically 2–10 × 10⁶ cells, adjusted to cell density	Short, pre-cooled centrifugation or direct cold solvent quenching, aspirate supernatant, extract pellet immediately in cold solvent.	Store at −80 °C; ship on dry ice
Microbial / Fermentation Pellets	Biomass volume determined by pilot extraction and target coverage	Fast filtration or direct quenching into pre-chilled solvent to arrest fast-turnover pools. Retain spent broth for extracellular rates.	Store at −80 °C; ship on dry ice
Plant & Animal Tissue Specimens	20–50 mg wet weight, depending on metabolic activity	Instant freeze-clamping or flash freezing in liquid nitrogen upon excision; cryogenic pulverization without intermediate thawing.	Store at −80 °C; ship on dry ice
Conditioned Culture Medium	≥ 200 μL matched supernatant	Sample matched culture supernatant across labeling time points; clarify by centrifugation (4 °C) to remove debris.	Store at −80 °C; ship on dry ice

Deliverables & Quantitative Datasets from TCA Cycle MFA

Deconvoluted TCA Cycle MID Matrix: Natural-abundance-corrected fractional labeling (M+0 to M+n) for citrate, isocitrate, cis-aconitate, α-KG, succinate, fumarate, malate, glutamate, and aspartate.
Extracellular Boundary Fluxes: Quantitative glucose, glutamine, and byproduct secretion rates providing stoichiometric boundaries for flux calculation.
Mathematical Model Specifications: Reaction network definitions, carbon atom transition mappings, and project configuration files.
Calculated Reaction Rates & Split Ratios: Net (v_net) and exchange (v_xch) fluxes with accompanying sensitivity analysis and confidence intervals.
Statistical Fit Diagnostics: Sum of squared residuals (SSR), Chi-square goodness-of-fit evaluation, and residual diagnostic plots.
Publication-Ready Pathway Maps: Vector graphics (PDF/SVG) illustrating TCA cycle carbon routing with flux-scaled arrow widths.

TCA cycle mass isotopologue distribution bar plot with M+4 vs M+5 split

Mass isotopologue distribution (MID) bar plot illustrating [U-¹³C₅]glutamine labeling across TCA cycle intermediates, resolving forward oxidative (M+4) vs. reductive carboxylation (M+5) routing.

Quantitative in vivo TCA cycle metabolic flux map with confidence intervals

Publication-oriented TCA cycle pathway flux map illustrating estimated reaction rates, glutamine anaplerosis, and quantitative uncertainty annotations.

Research Applications of TCA Cycle Pathway Flux Analysis & Anaplerosis

Oncology & Reductive Carboxylation: Quantify glutamine dependence, IDH1/2 mutational neomorphic activity, and reverse TCA flux supporting lipid synthesis in hypoxic tumors.
Mitochondrial Dysfunction & Complex II Defects: Measure flux consequences of SDH or FH alterations, succinate/fumarate accumulation, and oncometabolite signaling.
Immunometabolism & Macrophage Phenotypes: Characterize TCA cycle breaks at isocitrate dehydrogenase and succinate dehydrogenase during immune cell activation.
Cellular Energetics & Nutrient Adaptation: Track carbon redistribution between glucose and glutamine under nutrient limitation or pharmacological interventions.

How does TCA Cycle MFA distinguish oxidative cycling from reductive carboxylation?

By using [U-¹³C₅]glutamine, oxidative TCA cycling converts α-ketoglutarate (M+5) into M+4 succinate, fumarate, malate, and citrate. In contrast, reverse reductive carboxylation catalyzed by IDH1/2 adds unlabeled CO₂ to [U-¹³C₅]α-ketoglutarate, generating M+5 isocitrate/citrate and downstream M+3 malate. The ratio of M+5 to M+4 citrate provides an exact metric of the reductive-to-oxidative flux fraction.

How do you quantify pyruvate dehydrogenase (PDH) vs. pyruvate carboxylase (PC) entry?

Using [U-¹³C₆]glucose, PDH decarboxylates pyruvate (M+3) into M+2 acetyl-CoA, condensing with oxaloacetate to form M+2 citrate. PC carboxylates M+3 pyruvate directly into M+3 oxaloacetate, yielding M+3 malate, aspartate, and M+3/M+5 citrate. Stoichiometric network modeling resolves the relative split ratio between PDH and PC.

Why is chromatographic separation of citrate and isocitrate necessary?

Citrate and isocitrate are constitutional isomers with identical molecular weights and formula (C₆H₈O₇, m/z 191.0197). Because they occupy distinct positions in the TCA cycle and isocitrate is the direct substrate for IDH1/2, our LC-MS method achieves baseline chromatographic resolution to ensure accurate mass isotopologue assignment.

Can TCA Cycle MFA quantify anaplerosis from sources other than glutamine?

Yes. By utilizing custom tracers such as [U-¹³C₃]propionate, [U-¹³C₄]succinate, or [U-¹³C]amino acid mixtures, stoichiometric network modeling quantifies anaplerotic influx through succinyl-CoA, fumarate, and oxaloacetate.

What statistical metrics validate the calculated TCA cycle fluxes?

Calculated fluxes are validated using global Chi-square goodness-of-fit testing against measurement variance. Furthermore, parameter sensitivity analysis and confidence intervals are computed for reactions to verify that reported flux parameters are mathematically supported by the experimental dataset.